IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT05989711 · COMPLETED
Trial details
- NCT number
- NCT05989711
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2025-11-25
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.